期刊文献+
共找到444篇文章
< 1 2 23 >
每页显示 20 50 100
The Clinical Efficacy of Low-Dose Tacrolimus Combined with Tripterygium to Treat the Steroid-Resistant Nephrotic Syndrome 被引量:3
1
作者 Hongqi Ren Guofang Chen +4 位作者 Xuan Zhou Yan Li Qing Cai Shujing Han Rui Wang 《Open Journal of Nephrology》 2012年第4期97-104,共8页
Objective: To observe the clinical efficacy and safety of low dose tacrolimus (TAC) combined with tripterygium (TW) in treatment of steroid resistant nephritic syndrome (SRNS). Method: The patients, who were diagnosed... Objective: To observe the clinical efficacy and safety of low dose tacrolimus (TAC) combined with tripterygium (TW) in treatment of steroid resistant nephritic syndrome (SRNS). Method: The patients, who were diagnosed with mesangial proliferative glomerulonephritis (MesPGN) and focal segmental glomerulosclerosis (FSGS) by biopsy and failed to respond to a 3-month treatment with prednisone (1 mg/kg·d), were randomly divided into 2 groups (TAC + TW Group and TW Group). Initially TAC + TW group took TAC 0.05mg/(kg·d) 2 h after meal at 12 h interval. The plasma TAC level was examined after 3 days and was kept at 1.5 - 4 ng·ml;meanwhile, TW was given at 60 mg/d before meal. TW group only took TW (60 mg/d). The efficacy, adverse reactions and plasma TAC levels were observed in each group. Results: 1) Totally 20 SRNS patients completed the trial, 11 of TAC + TW Group and 9 of TW Group. There is no statistical difference between the two groups in terms of age, gender, duration since onset of the disease, blood pressure, 24 h UPQ, serum albumin, creatinine, cholesterol, triglyceride, FBG, kidney pathological categories, time of taking prednisone etc.;2) Urine protein started to decrease after 1 month treatment in both of TAC + TW and TW groups. By the 12th month of treatment, TAC + TW group showed 8 cases of complete remission (72.7%), 2 cases of partial remission (18.2%) and 1 case of no improvement (9.1%), while those of TW groups were 2 (22.2%), 4 (44.5%) and 3 (33.3%), respectively;3) With treatment, the TAC + TW Group patients’ plasma protein was significantly higher than that of pretreatment stage and recovered to normal level after 6 month of treatment. However, there was no significant plasma protein increase in TW Group. No obvious changes were observed on serum creatinine level of patients of both the two groups;4) The incidence of adverse reactions was not significantly different between the two groups. Conclusion: TAC + TW reduced proteinuria of SRNS patients, increased clinical remission rate and was tolerant to SRNS patients. We conclude that TAC + TW treatment is an effective way to treat patients with SRNS. 展开更多
关键词 steroid-resistant Nephrotic syndrome TACROLIMUS TRIPTERYGIUM Treatment OUTCOME
下载PDF
Crumbs homolog 2 mutation in two siblings with steroid-resistant nephrotic syndrome:Two case reports 被引量:1
2
作者 Jing Lu Yan-Nan Guo Li-Qun Dong 《World Journal of Clinical Cases》 SCIE 2021年第13期3056-3062,共7页
BACKGROUND Crumbs homolog 2(CRB2)is a recently discovered gene that is closely related to the maintenance of normal polarity in podocytes;mutations can directly lead to steroid-resistant nephrotic syndrome(SRNS).Howev... BACKGROUND Crumbs homolog 2(CRB2)is a recently discovered gene that is closely related to the maintenance of normal polarity in podocytes;mutations can directly lead to steroid-resistant nephrotic syndrome(SRNS).However,the characteristics of nephrotic syndrome(NS)caused by CRB2 mutations have not been described.CASE SUMMARY We report a novel compound heterozygous mutation of the CRB2 gene in two siblings with SRNS.The two siblings had edema,proteinuria,hypoproteinemia and hyperlipidemia.Both their father and mother had normal phenotypes(no history of NS).Whole exon sequencing(WES)of the family showed a novel compound heterozygous mutation,c.2290(exon 8)C>T and c.3613(exon 12)G>A.Glucocorticoid therapy(methylprednisolone pulse therapy or oral prednisone)and immunosuppressive agents(tacrolimus)had no effect.During a 3-year follow-up after genetic diagnosis by WES,proteinuria persisted,but the patient was healthy.CONCLUSION CRB2 mutations related to SRNS often occur in exons 7,10,and 12.Clinical manifestations of SRNS caused by CRB2 mutations are often less severe than in other forms of SRNS. 展开更多
关键词 steroid-resistant nephrotic syndrome Crumbs homolog 2 PROTEINURIA Compound heterozygous mutation GLOMERULOSCLEROSIS Renal biopsy Case report
下载PDF
NPHS2 Gene Mutation and Polymorphisms in Indonesian Children with Steroid-Resistant Nephrotic Syndrome 被引量:1
3
作者 Dedi Rachmadi Ani Melani Leo Monnens 《Open Journal of Pediatrics》 2015年第1期27-33,共7页
Objective:?Although several NPHS2 gene mutations and polymorphisms were described and?associated with clinical manifestation of steroid-resistant nephrotic syndrome (SRNS),?the?occurrence of these genetic abnormalitie... Objective:?Although several NPHS2 gene mutations and polymorphisms were described and?associated with clinical manifestation of steroid-resistant nephrotic syndrome (SRNS),?the?occurrence of these genetic abnormalities or variants appeared?to be influenced by race and ethnic group. We have investigated?probable mutations and variants in NPHS2 gene involved in SRNS and their association with clinical manifestations. Methods: We examined 28 children?with primary SRNS?whovisited?the pediatric nephrology division of 10 teaching hospitals in Indonesia. Molecular genetic studies of the NPHS2 gene were?conducted through screenings?for the exon 1, exon 2, and exon 8. The mutational analysis of NPHS2 was performed by DNA sequencing.?Fisher’s Exact Test was used to determine?the?correlation?between?NPHS2 polymorphisms and clinical manifestations.Results:?Seven?females (25%) and 21 males (75%)?participated in the study.?The mean age of the subjects with 95% CI is: 7.6 (6.1 - 9.0) years while the mean age at onset of disease with 95% CI is: 5.4 (3.9 - 7.0) years. Sixteen patients (57.14%) were younger than 6 years at the onset of disease. Seventeen (60.7%) subjects had normal eGFR, while 11 (39.3%) had chronic renal insufficiency. The mean eGFR of the subjects with 95% CI is: 111.4 (87.7 - 135.1) ml/min/1.73 m2. The mean systolic blood pressure with 95% CI is: 117.0 (108.9 - 125.1) mmHg and the mean diastolic blood pressure with 95% CI is: 77.0 (70.3 - 83.7) mmHg.?We identified 6 NPHS2polymorphisms,?i.e.?g.-52G>T, c.101A>G, g.-117C>T, c.288C>T, c.954C>T, and c.1038A>G and no mutation?was found. There was?no correlation?between?NPHS2 polymorphisms and clinical manifestations (p > 0.05). Conclusion: The?results demonstrate no mutation of NPHS2 gene, and the 6 NPHS2 gene polymorphisms that were identified have no correlation with the clinical manifestation in Indonesian children with SRNS. 展开更多
关键词 steroid-resistant Nephrotic syndrome NPHS2 Gene POLYMORPHISM
下载PDF
Renal biopsy reports in nephritic syndrome:Update
4
作者 Saeed Taheri 《World Journal of Nephrology》 2022年第2期73-85,共13页
BACKGROUND Nephritic syndrome(NiS)is a major indicator of serious renal diseases necessitating kidney biopsies for histopathological evaluations,but due to the lack of comprehensive reviews in the literature,the curre... BACKGROUND Nephritic syndrome(NiS)is a major indicator of serious renal diseases necessitating kidney biopsies for histopathological evaluations,but due to the lack of comprehensive reviews in the literature,the current understanding of the syndrome and its significance is limited.AIM To collect all the evidence retrievable from the literature on the diagnoses made on the renal biopsies performed for NiS as the indication to the procedure.METHODS A literature search was conducted to find studies reporting final diagnoses on renal biopsies in NiS patients.Data were pooled and analyzed with stratifications on age and regions.Meta-analyzes were performed using Stata v.9.RESULTS Overall,26414 NiS patients from the total number of 96738 kidney biopsy diagnoses reported by 47 studies from 23 countries from all continents(except sub-Saharan Africa)were found and analyzed.NiS was the indication for renal biopsy in 21%of the patient populations across the reviewed studies.Immunoglobulin A(IgA)nephropathy was the single most frequent diagnosis in these patients(approximately 38%)followed by lupus nephritis(approximately 8%)and Henoch Schönlein purpura(approximately 7%).IgA nephropathy was the most frequent diagnosis reported for the NiS patients from the East Asia,comprising half of all the cases,and least prevalent in South Asia.Considering the age subgroups,adult(vs pediatric or elderly)patients were by far the most likely age group to be diagnosed with the IgA nephropathy.A myriad of such regional and age disparities have been found and reported.CONCLUSION As the indication for renal biopsy,NiS represents a very distinctive epidemiology of final renal disease diagnoses compared to the other major syndromes. 展开更多
关键词 Renal biopsy nephritic syndrome Immunoglobulin A nephropathy DIAGNOSIS HISTOPATHOLOGY EPIDEMIOLOGY
下载PDF
Histopathology Review of Idiopathic Steroid Resistant Nephrotic Syndrome and Outcome in Children in North-West of Iran
5
作者 Mahtab Rahbar 《Open Journal of Nephrology》 2016年第4期188-199,共12页
Introduction: There is currently little information in the literature on the spectrum of histopathologic patterns in children presenting with idiopathic steroid-resistant nephrotic syndrome (iSRNS) in Iran. We conduct... Introduction: There is currently little information in the literature on the spectrum of histopathologic patterns in children presenting with idiopathic steroid-resistant nephrotic syndrome (iSRNS) in Iran. We conducted to compare the histopathologic distribution of different subtypes’ glomerular morphologic patterns in iSRNS and the clinical and biochemical parameters at the time of diagnosis and outcome of patients after immunosuppressive therapy. Material and Methods: This cross sectional study was done in two hundred children, aged 1 - 15 years, who were diagnosed for iSRNS and no response to 4 weeks of standard prednisone therapy (60 mg/m<sup>2</sup>/day) referred to nephropathology Department of Emam Reza hospital between 2005 and 2013. Demographic, clinical, laboratory, and histopathological data were retrieved from files and original renal biopsy reports. We discussed histopathologic diagnosis and outcome of iSRNS after initial therapy in patients separately. This study investigated prognostic effects of histopathologic pattern on outcome of iSRNS. Results: The study included 200 children with iSRNS: 141 (70.5%) were males and 59 (29.5%) females, with male-to-female ratio of 2.4:1. The mean age was 7.23 ± 4.37 years (range: 1 - 15 years). Upon pathologic investigation of iSRNS cases, focal segmental glomerulosclerosis (NOS subtype) was the first, with a highest prevalence at a rate of 102/200 (51%) and MGN was the last, at a rate of 7/200 (3.5%). Children with iSRNS secondary to MCD are more likely to achieve remission and have better long term prognostic value (P 0.00). Focal segmental glomerulosclerosis (FSGS) (Tip and Collapse subtypes) is more likely to have worse outcome in response to immunosuppressive therapy (P 0.04). Conclusions: This study defines the true spectrum of clinicohistopathology patterns underlying iSRNS in children in Northwest of Iran. Also this study shows that the response to cyclosporine can be correlated with the underlying histopathology patterns which have been earned by adequate renal biopsy. 展开更多
关键词 Idiopathic Nephrotic syndrome steroid-resistance HISTOPATHOLOGY OUTCOME CHILD
下载PDF
Immunoglobulin A glomerulonephropathy:A review
6
作者 Mohamad El Labban Salim Surani 《World Journal of Clinical Cases》 SCIE 2024年第8期1388-1394,共7页
In this editorial,we comment on the article by Meng et al published in the World Journal of Clinical Cases.We comprehensively review immunoglobulin A nephro-pathy(IgAN),including epidemiology,clinical presentation,dia... In this editorial,we comment on the article by Meng et al published in the World Journal of Clinical Cases.We comprehensively review immunoglobulin A nephro-pathy(IgAN),including epidemiology,clinical presentation,diagnosis,and management.IgAN,also known as Berger's disease,is the most frequent type of primary glomerulonephritis(GN)globally.It is mostly found among the Asian population.The presentation can be variable,from microscopic hematuria to a rapidly progressive GN.Around 50%of patients present with single or recurring episodes of gross hematuria.An upper respiratory infection and tonsillitis often precede these episodes.Around 30%of patients present microscopic hematuria with or without proteinuria,usually detected on routine examination.The diagnosis relies on having a renal biopsy for pathology and immunofluorescence microscopy.We focus on risk stratification and management of IgAN.We provide a review of all the landmark studies to date.According to the 2021 KDIGO(kidney disease:Improving Global Outcomes)guidelines,patients with non-variant form IgAN are first treated conservatively for three to six months.This approach consists of adequate blood pressure control,reduction of proteinuria with renin-angiotensin system blockade,treatment of dyslipidemia,and lifestyle modifications(weight loss,exercise,smoking cessation,and dietary sodium restrictions).Following three to six months of conservative therapy,patients are further classified as high or low risk for disease progression.High-risk patients have proteinuria≥1 g/d or<1 g/d with significant microscopic hematuria and active inflammation on kidney biopsy.Some experts consider proteinuria≥2 g/d to be very high risk.Patients with high and very high-risk profiles are treated with immunosuppressive therapy.A proteinuria level of<1 g/d and stable/im-proved renal function indicates a good treatment response for patients on immu-nosuppressive therapy. 展开更多
关键词 Immunoglobulin A nephropathy GLOMERULOnephritIS nephritic syndrome Angiotensin-converting enzyme inhibitor Angiotensin receptor blocker Systemic steroids Mycophenolate mofetil
下载PDF
Efficacy and safety of tacrolimus and low-dose prednisone in Chinese children with steroid-resistant nephrotic syndrome 被引量:5
7
作者 Hai-Xia Chen Qia Cheng +4 位作者 Fang Li Qing-Nan He Yan Cao Zhu-Wen Yi Xiao-Chuan Wu 《World Journal of Pediatrics》 SCIE CAS CSCD 2020年第2期159-167,共9页
Background Tacrolimus,a calcineurin inhibitor,is recommended by the recent guidelines from the Kidney Disease Improving Global Outcomes Group as the first-line treatment for steroid-resistant nephrotic syndrome(SRNS),... Background Tacrolimus,a calcineurin inhibitor,is recommended by the recent guidelines from the Kidney Disease Improving Global Outcomes Group as the first-line treatment for steroid-resistant nephrotic syndrome(SRNS),but its clinical application in China is still limited.We investigated the efficacy and safety of tacrolimus combined with low-dose corticosteroids in a population of Chinese children with SRNS.Methods In this prospective non-randomized,non-controlled study,Chinese children with SRNS who failed the previous full-dose prednisone treatment were given tacrolimus(0.1 mg/kg/day)and low-dose prednisone(0.25-0.50 mg/kg/day).We compared the overall remission rate(ORR)and adverse events in the follow-up period with this therapeutic regimen.Results A total of 76 children were enrolled into the study with an average follow-up period of 18±6 months(maximum 36 months).ORR achieved by the first,third,and sixth months was 94.7%,94.7%,and 96.0%,respectively.All patients who attained an initial tacrolimus trough concentration(FK506C0)>6 ng/mL(60.3%)achieved remission.The relative risk of relapse at FK506C0<3 ng/mL compared to 3-6 ng/mL,6-9 ng/mL,and 9-12 ng/mL was 2.3,3.2,and 16.9,respectively.During the follow-up period,adverse effects that had been previously reported were rare.Conclusions Combination of tacrolimus and low-dose prednisone was safe and effective for the treatment of children with SRNS,with high remission rates observed as early as the first month.Relapses were infrequent,but tended to increase significantly with decreases in FK506C0. 展开更多
关键词 CHILDREN Low-dose prednisone steroid-resistant nephrotic syndrome TACROLIMUS
原文传递
Management and outcomes of acute post-streptococcal glomerulonephritis in children
8
作者 Leong Tung Ong 《World Journal of Nephrology》 2022年第5期139-145,共7页
Acute post-streptococcal glomerulonephritis(APSGN)is the major cause of acute glomerulonephritis among children,especially in low-and middle-income countries.APSGN commonly occurs following pharyngitis due to the acti... Acute post-streptococcal glomerulonephritis(APSGN)is the major cause of acute glomerulonephritis among children,especially in low-and middle-income countries.APSGN commonly occurs following pharyngitis due to the activation of antibodies and complements proteins against streptococcal antigens through the immune-complex-mediated mechanism.APSGN can be presented as acute nep-hritic syndrome,nephrotic syndrome,and rapidly progressive glomerulonephritis,or it may be subclinical.The management of APSGN is mainly supportive in nature with fluid restriction,anti-hypertensives,diuretics,and renal replacement therapy with dialysis,when necessary,as the disease is self-limiting.Congestive heart failure,pulmonary edema,and severe hypertension-induced encephalopathy might occur during the acute phase of APSGN due to hypervolemia.APSGN generally has a favorable prognosis with only a small percentage of patients with persistent urinary abnormalities,persistent hypertension,and chronic kidney disease after the acute episode of APSGN.Decreased complement levels,increased C-reactive protein,and hypoalbuminemia are associated with disease severity.Crescent formations on renal biopsy and renal insufficiency on presentation may be the predictors of disease severity and poor outcomes in APSGN in children. 展开更多
关键词 Post-streptococcal glomerulonephritis PEDIATRICS Acute kidney injury Nephrotic-range proteinuria nephritic syndrome
下载PDF
基于蓄血证概论浅析难治性肾病综合征的治疗 被引量:1
9
作者 王然 曹继刚 +3 位作者 蔚文垚 王齐开 姜兴宇 颜强 《中外医学研究》 2023年第2期121-124,共4页
难治性肾病综合征(refractory nephritic syndrome,RNS)是慢性肾脏病治疗中最为棘手、预后较差、最易引起肾功能下降的肾病类型。从临床角度看,蓄血证与RNS有相似之处,RNS病程长,病机复杂,在临床中往往治疗效果不甚满意,随着病情迁延,... 难治性肾病综合征(refractory nephritic syndrome,RNS)是慢性肾脏病治疗中最为棘手、预后较差、最易引起肾功能下降的肾病类型。从临床角度看,蓄血证与RNS有相似之处,RNS病程长,病机复杂,在临床中往往治疗效果不甚满意,随着病情迁延,往往会伴有血瘀、水湿、气虚等虚实夹杂的表现,与蓄血证相符。本研究通过门诊搜集信息,然后结合蓄血证相关理论,从病机、证候、治疗几方面阐述RNS与蓄血证之间的相互关系,并列举验案加以分析佐证,以此分析蓄血证理论治疗RNS的可行性,以期为临床提高RNS提供参考。 展开更多
关键词 难治性肾病综合征 脾肾亏虚型 蓄血证
下载PDF
以COL4A5基因突变为主Alport综合征临床分析
10
作者 刘益男 张永桃 +4 位作者 余韶卫 罗立荣 黄逸辉 于生友 于力 《实用医学杂志》 CAS 北大核心 2023年第21期2768-2774,共7页
目的对COL4A5基因突变的X连锁遗传的Alport综合征(X-linked Alport syndrome,XLAS)患儿的临床表型及基因突变类型进行分析,探讨XLAS患儿与肾病综合征肾炎型的关系。方法纳入2016年4月至2023年4月期间在医院经二代测序发现COL4A5基因突... 目的对COL4A5基因突变的X连锁遗传的Alport综合征(X-linked Alport syndrome,XLAS)患儿的临床表型及基因突变类型进行分析,探讨XLAS患儿与肾病综合征肾炎型的关系。方法纳入2016年4月至2023年4月期间在医院经二代测序发现COL4A5基因突变最终确诊为Alport综合征的32例患儿,回顾性分析其临床病理特征与基因突变特点。结果XLAS患儿平均起病年龄(3.68±2.07)岁,平均确诊年龄(6.56±2.95)岁,以孤立性血尿起病12例(37.5%),以血尿和蛋白尿起病8例(25%),以肾病综合征肾炎型起病12例(37.5%),患儿家族史阳性有11例(34.4%),眼部病变3例(9.37%),耳部病变6例(18.75%),后期随访发现7例(21.87%)患儿已发展为慢性肾脏病(chronic kidney disease,CKD)。21例患儿行肾脏组织穿刺活检,电镜表现为基底膜变薄(弥漫性或节段性)13例(61.9%),基底膜厚薄不均8例(38.09%);光镜:局灶节段肾小球硬化(FSGS)2例(9.52%),系膜增生性肾小球肾炎(Ms PGN)11例(52.38%),微小病变(MCD)8例(38.09%)。基因突变类型分为错义突变12例(37.5%)、剪切位点突9例(28.12%)、无义突变6例(18.75%)、缺失突变3例(9.37%)、移码突变2例(6.25%)。遗传突变22例(68.75%);自发突变10例(27.02%)。结论XLAS患儿在疾病早期临床表现和病理特征均不典型,进展缓慢,部分患儿早期易误诊为肾病综合征肾炎型,对于疑似本病尽早完善基因检测,合理药物选择,科学预测预后。 展开更多
关键词 COL4A5 ALPORT综合征 肾病综合征肾炎型 临床
下载PDF
儿童原发性肾病综合征不同种类糖皮质激素治疗的临床研究 被引量:34
11
作者 成学琴 鲍华英 +4 位作者 张爱华 吴红梅 张维真 陈颖 韩媛 《临床儿科杂志》 CAS CSCD 北大核心 2013年第2期159-161,共3页
目的观察两种不同剂型的糖皮质激素治疗原发性肾病综合征的效应及不良反应。方法将40例初治的原发性肾病综合征患儿随机分为两组,分别以甲基泼尼松龙(甲泼尼龙)和泼尼松作为诱导缓解治疗的药物,观察比较两组患儿的治疗效果及不良反应。... 目的观察两种不同剂型的糖皮质激素治疗原发性肾病综合征的效应及不良反应。方法将40例初治的原发性肾病综合征患儿随机分为两组,分别以甲基泼尼松龙(甲泼尼龙)和泼尼松作为诱导缓解治疗的药物,观察比较两组患儿的治疗效果及不良反应。结果两组患儿对激素反应(激素敏感、激素依赖、激素耐药)的差异无统计学意义。对于激素敏感患儿,甲泼尼龙组尿蛋白阴转时间(9.5±1.1)d少于泼尼松组的(14.7±1.4)d,差异有统计学意义(P<0.05);两组患儿在发生高血压、感染次数、血糖异常及肾上腺皮质功能不全方面的差异无统计学意义(P均>0.05);口服甲泼尼龙组更易出现多毛(面部,背部为主),兴奋度明显增高,且柯兴综合征较严重,两组比较差异有统计学意义(P均<0.05)。结论甲泼尼龙诱导肾病综合征缓解优于泼尼松,可缩短激素治疗疗程,但同时有较多的糖皮质激素不良反应。 展开更多
关键词 肾病综合征 甲基泼尼松龙 泼尼松 儿童
下载PDF
肾病综合征患者血清Ig和补体C_3的测定及临床意义探讨 被引量:25
12
作者 姚磊 向阳 +3 位作者 康铃 蒋栋能 罗福康 张征 《重庆医学》 CAS CSCD 2006年第18期1656-1657,共2页
目的通过对肾病综合征和其他常见的几类肾脏疾病进行血清免疫球蛋白(Ig)的测定,探讨肾病综合征体液免疫功能的变化。方法采用散射免疫比浊法(nephelometry)和酶联免疫吸附法(ELISA)分别对肾病综合征(NS)、慢性肾小球肾炎(CN)、慢性肾衰... 目的通过对肾病综合征和其他常见的几类肾脏疾病进行血清免疫球蛋白(Ig)的测定,探讨肾病综合征体液免疫功能的变化。方法采用散射免疫比浊法(nephelometry)和酶联免疫吸附法(ELISA)分别对肾病综合征(NS)、慢性肾小球肾炎(CN)、慢性肾衰竭(CRF)氮质血症期和尿毒症期及正常对照组进行Ig和补体C3的测定。结果NS患者IgG为(5.92±3.71)g/L,明显低于其他各组(P<0.01),而IgM和IgE水平高于其他肾病组及正常对照组(P<0.05),慢性肾衰竭(CRF)尿毒症期血清补体C3水平低于其他各组(P<0.05)。结论血清Ig测定在肾病综合征的诊断和治疗过程中具有重要的临床意义。 展开更多
关键词 免疫球蛋白 补体C3 肾病综合征
下载PDF
环孢素A治疗儿童难治性肾病综合征疗效观察 被引量:28
13
作者 简珊 何艳燕 +1 位作者 宋红梅 魏珉 《临床儿科杂志》 CAS CSCD 北大核心 2010年第4期330-333,370,共5页
目的观察环孢素A(CsA)治疗儿童难治性肾病综合征(RNS)的临床疗效。方法回顾性分析CsA联合泼尼松治疗儿童RNS的疗效,监测CsA治疗前后相关生化指标,并观察药物不良反应。27例患儿中激素抵抗14例,激素依赖6例,频复发7例;其中25例行肾活检,... 目的观察环孢素A(CsA)治疗儿童难治性肾病综合征(RNS)的临床疗效。方法回顾性分析CsA联合泼尼松治疗儿童RNS的疗效,监测CsA治疗前后相关生化指标,并观察药物不良反应。27例患儿中激素抵抗14例,激素依赖6例,频复发7例;其中25例行肾活检,微小病变型肾病15例,局灶性节段性硬化性肾小球肾炎4例,系膜增生性肾小球肾炎4例,膜增殖性肾小球肾炎2例。CsA剂量2~5mg/(kg·d),疗程6~24个月(平均11.6±6.6个月)。结果完全缓解15例,部分缓解9例,无效3例,总有效率88.9%。激素抵抗组、激素依赖组及频复发组的疗效差异无统计学意义。激素抵抗组完全缓解者起效时间较激素依赖组及频复发组长。不同病理类型的RNS患儿对CsA的治疗反应差异无统计学意义。血胆固醇≤9.0mmol/L组的完全缓解率较血胆固醇>9.0mmol/L组高。CsA的主要不良反应依次为多毛、轻度肝损、血肌酐升高等,均不影响CsA继续使用。结论CsA联合泼尼松治疗难治性肾病综合征安全有效。 展开更多
关键词 环孢素A 肾病综合征 儿童
下载PDF
中西医结合治疗小儿原发性肾病综合征随机对照试验的Meta分析 被引量:25
14
作者 吕彩兰 戴恩来 +2 位作者 吴建军 魏锦慧 徐厚谦 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2013年第1期87-93,98,共8页
目的评价中西医结合治疗小儿原发性肾病综合征的疗效。方法计算机检索2000~2010年PubMed、Medline、中国生物医学文献光盘数据库(CBM disc)、中文期刊网全文数据库(CNKI)、中国优秀博硕士学位论文全文数据库(CDMD)、万方数据库、Cochra... 目的评价中西医结合治疗小儿原发性肾病综合征的疗效。方法计算机检索2000~2010年PubMed、Medline、中国生物医学文献光盘数据库(CBM disc)、中文期刊网全文数据库(CNKI)、中国优秀博硕士学位论文全文数据库(CDMD)、万方数据库、Cochrane Library(2010,第2期);并手工检索纳入文献的参考文献、相关学位论文和会议论文集。由2名研究人员分别独立检索、筛选文献,并独立对纳入文献依据Jadad量表进行质量评价和数据提取。用Rev-Man 5.1.5软件进行Meta分析。结果①共纳入17篇文献,980例患者,其中治疗组535例,对照组445例。除1篇Jadad评分3分的文献外,其余均为1~2分的低质量文献。各研究均明确指出基线均衡,具有可比性。有2篇文献提到使用随机数字表,其余文献只提到随机分组,但并未详细描述随机序列的产生方法。所有纳入文献均未对随机分配方案进行隐藏,均未使用盲法;②Meta分析结果显示:中西医结合疗法治疗小儿原发性肾病综合征在减少24h尿蛋白定量(UPT)(SMD-0.74,95%CI[-1.12,-0.37])、升高血浆白蛋白(ALB)(SMD 0.64,95%CI[0.38,0.90])、降低血脂(TC:MD-1.24,95%CI[-1.80,-0.69];TG:MD-0.41,95%CI[-0.66,-0.17])、减少复发率(RR 0.39,95%CI[0.30,0.52])和缩短水肿消退时间(MD-4.30,95%CI[-5.19,-3.41])方面优于常规激素或激素加免疫抑制剂治疗,且差异有统计学意义。结论在激素或激素加免疫抑制剂常规治疗的基础上加用中医药治疗,对小儿原发性肾病综合征患者24hUPT、血脂(TC、TG)、复发率的降低,水肿消退时间的缩短及升高ALB方面的作用优于常规治疗,且敏感性分析未能从实质上改变Meta分析的结果,但纳入该Meta分析的文献方法学质量较低,而且可能存在发表性偏倚,因此,尚有待于设计严密规范的大样本、多中心、随机双盲对照研究进一步证实。 展开更多
关键词 META分析 随机对照试验 原发性肾病综合征 小儿
下载PDF
初诊为原发性肾炎型肾病综合征患儿的病因构成分析——对国内儿童原发性肾病综合征临床分型的商榷 被引量:15
15
作者 张宏文 姚勇 +3 位作者 苏白鸽 王芳 徐可 肖慧捷 《中国循证儿科杂志》 CSCD 北大核心 2018年第5期364-366,共3页
目的总结初诊为原发性肾炎型肾病综合征患儿的病因构成情况,探讨国内儿童原发性肾病综合征临床分型的价值。方法纳入2013年1月1日至2017年12月31日北京大学第一医院儿科收治的病初临床诊断为原发性肾炎型肾病综合征患儿,且经肾脏病理检... 目的总结初诊为原发性肾炎型肾病综合征患儿的病因构成情况,探讨国内儿童原发性肾病综合征临床分型的价值。方法纳入2013年1月1日至2017年12月31日北京大学第一医院儿科收治的病初临床诊断为原发性肾炎型肾病综合征患儿,且经肾脏病理检查或基因突变分析明确最终诊断者,排除继发性、遗传性肾病综合征及伴有明显肉眼血尿者。原发性肾病综合征的临床分型参照中华医学会儿科学分会肾脏病学组标准。截取患儿入院时一般情况、入院时诊断和临床分型、肾脏穿刺活检病理检查结果、基因检测结果和最终诊断。结果 28例临床分型为原发性肾炎型肾病综合征的患儿进入本文分析,占同期收治的原发性肾病综合征的10.6%(28/265)。分型依据:25例(89.3%)为镜下血尿,2例为高血压(7.2%),1例为肾功能异常(3.6%)。28例均进行了肾穿刺活检,11例行基因检测,最终诊断:原发性肾炎型肾病综合征5例(17.9%),Ig A肾病10例(35.7%),Alport综合征8例(28.6%),遗传性肾病综合征3例(10.7%),急性感染后肾小球肾炎和纤维素性肾小球肾炎各1例(3.6%)。结论儿童原发性肾炎型肾病综合征临床分型诊断的主要依据为镜下血尿,通过肾脏病理检查和基因检测明确病因,以Ig A肾病、遗传性肾脏疾病等居多,因此,临床诊断儿童原发性肾炎型肾病综合征应该慎重。 展开更多
关键词 儿童 肾病综合征 肾炎型
下载PDF
难治性肾病综合征患儿51例临床与病理关系及预后分析 被引量:8
16
作者 沈辉君 刘爱民 +3 位作者 戴宇文 夏永辉 王亚萍 毛建华 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第17期1319-1320,1334,共3页
目的探讨难治性肾病综合征患儿临床与病理的关系及转归。方法选择难治性肾病51例,其中单纯型31例,肾炎型20例;难治类型有激素耐药25例,频复发20例,激素依赖6例;病理类型微小病变型(MCD)19例,系膜增殖性肾小球肾炎(MsPGN)、IgM肾病(IgMN)... 目的探讨难治性肾病综合征患儿临床与病理的关系及转归。方法选择难治性肾病51例,其中单纯型31例,肾炎型20例;难治类型有激素耐药25例,频复发20例,激素依赖6例;病理类型微小病变型(MCD)19例,系膜增殖性肾小球肾炎(MsPGN)、IgM肾病(IgMN)各10例,IgA肾病(IgAN)6例,局灶节段性肾小球硬化3例,膜增殖性肾小球肾炎、膜性肾病、肾小球硬化各1例。患儿经糖皮质激素长程疗法,部分加用雷公藤总苷片或环磷酰胺(CTX)针,对其进行随访并分析。结果临床类型与病理类型、难治类型关系密切,有显著统计学意义(χ2=29.91.20.26Pa<0.001);MCD及IgMN近期疗效较MsPGN及IgAN有显著差异(QCMH=21.14P<0.001),远期疗效无显著差异(P>0.05)。持续完全缓解36例(70.6%)。结论激素长程疗法及联合雷公藤总苷片或CTX疗效满意,但长期复发及激素依赖患儿的病因、病理转型及治疗方案仍需关注。 展开更多
关键词 肾病综合征 临床 病理 预后 儿童
下载PDF
肾病综合征患儿的行为、家庭环境及其父母生活质量的调查 被引量:19
17
作者 董玲 吴升华 +1 位作者 卞兰峥 顾胜英 《中国心理卫生杂志》 CSSCI CSCD 北大核心 2004年第10期702-704,698,共4页
目的 :了解肾病综合征患儿 (NS)的行为、家庭环境及其父母的生活质量 ,为NS患儿及其父母的心理干预治疗提供理论依据。方法 :分别采用Achenbach’s儿童行为量表 (CBCL)、家庭环境量表中文版 (FES -CV)及生活质量综合评定问卷 (GQOLI -74... 目的 :了解肾病综合征患儿 (NS)的行为、家庭环境及其父母的生活质量 ,为NS患儿及其父母的心理干预治疗提供理论依据。方法 :分别采用Achenbach’s儿童行为量表 (CBCL)、家庭环境量表中文版 (FES -CV)及生活质量综合评定问卷 (GQOLI -74)调查男性NS患儿及其父母 3 2例 ,对照组为正常男孩及其父母 45例。结果 :NS组男孩行为问题检出率为 3 1% ,高于对照组 2 0 % ,但无统计学意义 ( χ2 =1 3 ,P >0 0 5 ) ;男孩在体诉 (t =3 0 2 )、社交退缩 (t=2 13 )及攻击性 (t =3 1) 3个行为因子上得分与对照组差异显著 (P <0 0 5~ 0 0 1)。家庭环境在娱乐性上与对照组有显著差异 (P <0 0 5 )。而父母生活质量则除住房、社区服务、生活环境、自尊、社会支持、人际交往能力及婚姻与家庭外 ,其余因子均与对照组存在显著差异 (P <0 0 1)。结论 :NS患儿的某些行为及其父母的生活质量有改变 ,应引起医护人员的重视 ,适当的心理干预治疗是必要的。 展开更多
关键词 对照组 生活质量 患儿 肾病综合征 行为 心理干预治疗 调查 父母 家庭环境 得分
下载PDF
应用“快乐护理”提高肾病综合征患儿激素服药依从性的实践 被引量:19
18
作者 周成 任晓碧 +3 位作者 谢敏叶 赵玲玲 戴一希 贾玉双 《中国护理管理》 CSCD 2014年第3期315-316,共2页
目的:探讨"快乐护理"对提高肾病综合征患儿激素服药依从性的效果。方法 :通过营造"快乐护理"氛围、建立护理"快乐链"、开设"快乐课堂"、掌握不同年龄患儿喂药技巧、寻求促进患儿服药的快乐方... 目的:探讨"快乐护理"对提高肾病综合征患儿激素服药依从性的效果。方法 :通过营造"快乐护理"氛围、建立护理"快乐链"、开设"快乐课堂"、掌握不同年龄患儿喂药技巧、寻求促进患儿服药的快乐方法等措施,观察实施"快乐护理"后患儿激素服药依从性的变化。结果 :肾病综合征患儿激素服药依从性从实施"快乐护理"前的72.7%提高到实施后的89.3%。结论 :"快乐护理"可提高肾病综合征患儿激素服药依从性。 展开更多
关键词 快乐护理 肾病综合征 服药依从性 儿童
下载PDF
他克莫司与环磷酰胺治疗难治性肾病综合征有效性和安全性的Meta分析 被引量:34
19
作者 陈艳霞 冯益宇 +1 位作者 房向东 涂卫平 《中国全科医学》 CAS CSCD 北大核心 2014年第17期2008-2010,2014,共4页
目的评价他克莫司(FK506)与环磷酰胺(CTX)治疗难治性肾病综合征(RNS)的有效性和安全性。方法计算机检索PubMed、CNKI、CBM、万方、维普等全文数据库,筛选FK506与CTX治疗RNS的随机对照试验,采用Stata 12.0软件进行统计分析。结果最终纳入... 目的评价他克莫司(FK506)与环磷酰胺(CTX)治疗难治性肾病综合征(RNS)的有效性和安全性。方法计算机检索PubMed、CNKI、CBM、万方、维普等全文数据库,筛选FK506与CTX治疗RNS的随机对照试验,采用Stata 12.0软件进行统计分析。结果最终纳入5篇文献,共包括308例RNS患者,其中试验组155例,对照组153例。Meta分析结果显示,治疗后两组完全缓解率〔RR=1.619,95%CI(1.158,2.363),Z=2.82,P=0.005〕、部分缓解率〔RR=1.272,95%CI(1.024,1.579),Z=2.17,P=0.030〕间差异均有统计学意义,总缓解率〔RR=0.994,95%CI(0.826,1.195),Z=0.07,P=0.945〕、不良反应发生率〔RR=0.763,95%CI(0.577,1.088),Z=1.91,P=0.056〕间差异均无统计学意义。3篇文献报道了治疗6个月后完全缓解率、部分缓解率、总缓解率及不良反应发生率,Meta分析结果显示,两组完全缓解率〔RR=1.620,95%CI(0.898,2.923),Z=1.60,P=0.109〕、部分缓解率〔RR=1.051,95%CI(0.649,1.702),Z=0.15,P=0.878〕、不良反应发生率〔RR=0.712,95%CI(0.424,1.194),Z=1.71,P=0.087〕间差异均无统计学意义;总缓解率〔RR=1.012,95%CI(0.809,1.265),Z=2.18,P=0.030〕间差异有统计学意义。结论与经典治疗药物CTX比较,FK506能提高RNS患者的完全缓解率和部分缓解率,治疗6个月时,患者总缓解率明显提高,FK506治疗RNS的有效性较CTX高,两者安全性相似。 展开更多
关键词 肾病综合征 他克莫司 环磷酰胺 治疗结果 安全 META分析
下载PDF
肾病综合征患儿的个性、行为及社会适应能力对照研究 被引量:14
20
作者 戴文献 王广吉 齐娅贤 《中国临床心理学杂志》 CSCD 2003年第3期223-224,共2页
Objective:To understand the psychological characteristics of nephrotic syndrome.Methods:The personality characteristics,intelligence and social adaptive behavior(SAB) of 67 moderate to severe nephrotic syndrome aged 7... Objective:To understand the psychological characteristics of nephrotic syndrome.Methods:The personality characteristics,intelligence and social adaptive behavior(SAB) of 67 moderate to severe nephrotic syndrome aged 7~14 years were measured by means of EPQ,CBCL,CRT and SAB scales.Results:The EPQ-N score of nephritic syndrome group was higher than that of control group( P <0.001).The occurrence rate of behavior problem was 31%.The abnormal behavior in boys was assault,while in girls was social flinch.The mean IQ in nephritic syndrome group was 105±13 and there was no significant difference between the two groups( P >0.05).The nephritic group got a significantly lower social/self direction factor score than the control group.Conclusion:The results showed that nephritic syndrome possessed personality characteristics of neuroticism and obvious behavior problems;and their social adaptive behavior,particularly social/self-direction factor,was significantly lower than that of normal children. 展开更多
关键词 肾病综合征 小儿 个性 行为 社会适应能力 心理学
下载PDF
上一页 1 2 23 下一页 到第
使用帮助 返回顶部